libratherapeutics.com | Libra Therapeutics | Developing therapeutics for neurodegenerative

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.libratherapeutics.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Libra Therapeutics \| Developing therapeutics for neurodegenerative
Description	Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative
Keywords	N/A

Server Information

WebSite	libratherapeutics.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

libratherapeutics.com Valuation

US$7,145,531

Last updated: 2023-05-02 06:45:18

libratherapeutics.com has Semrush global rank of 1,481,248. libratherapeutics.com has an estimated worth of US$ 7,145,531, based on its estimated Ads revenue. libratherapeutics.com receives approximately 824,485 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, libratherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$7,145,531
Daily Ads Revenue	US$6,596
Monthly Ads Revenue	US$197,877
Yearly Ads Revenue	US$2,374,515
Daily Unique Visitors	54,966
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
libratherapeutics.com.	A	599	IP: 23.236.62.147
libratherapeutics.com.	NS	3600	NS Record: ns73.domaincontrol.com.
libratherapeutics.com.	NS	3600	NS Record: ns74.domaincontrol.com.
libratherapeutics.com.	MX	3600	MX Record: 0 libratherapeutics-com.mail.protection.outlook.com.
libratherapeutics.com.	TXT	3600	TXT Record: google-site-verification=Xm6TxpXVJ857EaYjcysT3rDEppoRGIlC9kY-AnN8nt4
libratherapeutics.com.	TXT	3600	TXT Record: NETORGFT7079326.onmicrosoft.com
libratherapeutics.com.	TXT	3600	TXT Record: v=spf1 include:secureserver.net -all

HtmlToTextCheckTime:2023-05-02 06:45:18

top of page Home News Careers Contact Restoring Cellular Balance Developing novel therapeutics for neurodegenerative disease Continue About Libra Therapeutics Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases. These include amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer’s, Parkinson’s, and Huntington’s disease, which are all characterized by cellular disequilibrium caused by the production and decreased clearance of neurotoxic proteins. The company’s therapeutic platform is uniquely positioned to discover and develop small molecule drugs with distinct molecular approaches that can 1) increase autophagy to more rapidly clear toxic proteins and 2) attenuate the production of neurotoxic proteins. About Contact INVESTORS News Oct 19, 2021 Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer SAN DIEGO -- Libra Therapeutics, Inc. today

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 24 Oct 2021 17:41:44 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.libratherapeutics.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635097304.83099930519811452
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=96
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7CWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjjm0fy8KxWG83idJ9HAMLr,m0j2EEknGIVUW/liY8BLLl45Bek9v359fF7CbvAfPLwXK4CpcIIKXm19QkScmIm+,2d58ifebGbosy5xc+FRaluAGDcf9rYs1gcjFnthk7o70Hn+bzPbiNIqXLoD9dmQFApDfyCnNEnuOx5lJiwrhGg==,2UNV7KOq4oGjA5+PKsX47Acb9tPMRl4SW2bhgA9BBDtYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,X5dRh+rzcwmxSuOfFJGa++qBIXwD9dtATx1n5kQX/UGTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,0gGrL7iazMoiuqlb7dEO3cR8PvtCB17SVPSjO4ttbp/fIAvXI1+LW5upuc45n2SZBFNjNRTmQgt5BwMmIVG00A==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sun, 24 Oct 2021 17:41:45 GMT
content-type: text/html; charset=UTF-8
content-length: 517324
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"afee822604265e5680c6498bcb4180b1"
content-language: en
strict-transport-security: max-age=120
age: 448852
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Tue, 19 Oct 2021 13:01:12 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YUbeT7LzRsCznpqBWyjuyLU=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVho24eAEbfscWhcpKw1HIzZ,m0j2EEknGIVUW/liY8BLLk4c1TjfDNjZRW4gaj81MvVkavE0ZtMXws1mfakihq4B,2d58ifebGbosy5xc+FRalsDmyhxJC0PlUxqx2RhYuSxNywFbaK0V3JxRJiKQNli2cwl/k3RNCJuSwgaosCahQw==,2UNV7KOq4oGjA5+PKsX47KH2oyd+0TIFyhZ1fYl9fAAfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635097305.00031872148939997
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131116d00b0a0b8d3e178e4cd2e80e2e60748a814a094eade39d1fb4e7f8a88feeb72ce5ea408c20da05f178505b2a0f583; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

libratherapeutics.com Whois Information

Domain Name: LIBRATHERAPEUTICS.COM
Registry Domain ID: 2555925447_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-29T03:21:51Z
Creation Date: 2020-08-27T14:58:07Z
Registry Expiry Date: 2022-08-27T14:58:07Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS73.DOMAINCONTROL.COM
Name Server: NS74.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T00:11:14Z <<<

libratherapeutics.com valuation and analysis